 Inhibition of phosphodiesterase type 0 reduces obesity and cardiometabolic syndrome in mice Central obesity with cardiometabolic syndrome (CMS) is a major global contributor to human disease, and effective therapies are needed. Here, we show inhibiting cyclic-GMP selective... Published October 0, 0000 Research In-Press Preview 